Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 24, 2013
Representatives from the White House, U.S. Military, Departments of Labor and Veterans Affairs, Catalent, and Partnering Blackstone Portfolio Companies Meet to Advance Hiring of Veterans
read more
Catalent Pharma Solutions, a leading global drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky. The company is to invest nearly...
read more
Thursday, February 16, 2012
Catalent Pharma Solutions, a leading global drug delivery technology company, and NewMarket Pharmaceuticals LLC have entered into an agreement to jointly formulate and develop a portfolio of products for treating production and companion animals ...
read more
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, and Adamas Pharmaceuticals Inc., today announced an agreement for Phase 3 clinical trials ...
read more
Catalent has signed an agreement with Spicona to develop a virus-like protein (VLP)-based vaccine against COVID-19.
read more
Humanigen has dosed the first COVID-19 patient in its study for lenzilumab, the company’s GM-CSF monoclonal antibody.
read more
Tuesday, December 10, 2019
Catalent has completed clinical production of Bridge Therapeutics’ opioid addiction development therapeutic product, BT-219.
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
Thursday, October 07, 2021
Catalent, a global leader in clinical supply services, today announced the opening of its new clinical supply facility, strategically located in the Shiga prefecture of Japan, in response to increased demand for end-to-end services, including primary...
read more
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has announced the opening of its clinical supply facility, located within its 200,000 sq. ft....
read more
Wednesday, October 21, 2015
Catalent Pharma Solutions has announced that Wetteny Joseph has been appointed as its new President, Clinical Supply Services.
read more
Thursday, February 14, 2019
Catalent announced that Alessandro Maselli has been appointed President and Chief Operating Officer, a new position within Catalent.
read more
Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced the appointment of Kunal Jaiswal to the role of Vice President, Strategic ...
read more
Wednesday, December 28, 2016
Catalent Pharma Solutions has announced the appointment of Dr. Joseph (Joe) Reo to the role of Director of Global Scientific Affairs. In his new post, Dr. Reo will be responsible for Catalent’s internal scientific affairs to evolve the company’s ...
read more
Monday, November 21, 2016
Catalent Pharma Solutions has announced the appointment of Ms. Shannon Trilli in the newly created role of Director of Corporate Responsibility.
read more